The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...

Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...

The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...

MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...

Without timely diagnosis and intervention, PCOS can lead to more severe health complications such as hypertension, Type 2 ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebatin ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...

Prediabetes, often considered the step before diabetes, is when you have higher than usual blood glucose (blood sugar) levels ...

This week's healthcare newsletter looks at the prospect for prior authorization reform for prescription drugs and a major FTC ...

Sen. Mike Braun has a unique opportunity to hold Novo Nordisk accountable for discontinuing insulin drug Levemir.

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.